Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Am J Med Sci. 2013 Feb;345(2):143–148. doi: 10.1097/MAJ.0b013e31825d32c6

Table 2.

Summary of clinically available rapid molecular resistance testing assays for Mycobacterium tuberculosis

Molecular Testing
Method
Turn-around
time
Sensitivity Specificity Advantages Limitations
Line probe assay
  • INNO-LipA® Rif.TB

  • Genotype®MTBDR

  • Genotype®MTBDR plus

6 – 48 hours Rifampin resistance:
-culture isolates:
  95–100%
- clinical specimens:
  80–100%

Isoniazid resistance:
  72–92%
Rifampin resistance:
- culture isolates:
  92–100%
- clinical specimens:
  100%

Isoniazid resistance:
  95–100%
- rapid

-sensitivity in
detecting rifampin
resistance mutations
- inability to differentiate
silent mutations from those
responsible for rifampin
resistance

- limited accuracy in
detecting isoniazid
resistance mutations
RT-PCR coupled with
molecular beacons
2 hours Rifampin resistance:
  86–100%

Isoniazid resistance:
  76–94%
Rifampin resistance:
  95–100%

Isoniazid resistance:
  100%
- rapid

- accuracy in
detecting rifampin
resistance mutations
within the target
region

- high throughput

- elimination of cross-
contamination

- hands-free
processing

- capacity to detect
novel mutations
- expensive

- inability to detect mutations
outside of pre-specified
target region

- limited accuracy in
detecting isoniazid
resistance mutations
Pyrosequencing 2 – 48 hours Rifampin resistance:
92–100%

Isoniazid resistance:
64–81%
Rifampin resistance:
92–100%

Isoniazid resistance:
100%
- provides exact DNA
sequences

- high throughput
- accuracy limited in lengthy
DNA sequences

- limited accuracy in
detecting isoniazid
resistance mutations